Disclaimer: This website connects patients with licensed healthcare providers who can evaluate medical conditions and prescribe medications when appropriate
Kidney and cardiovascular outcomes SURPASS-4 kidney composite HR 0.58, slower eGFR decline (-1.4 vs -3.6 mL/min/1.73m2/yr), UACR -6.8% vs +36.9%
In the small published human studies to date, BPC-157 was well tolerated, with no meaningful changes in cardiac, hepatic, renal, or metabolic markers
I wouldnt mind betting that some of the GPs and nurses were concerned at this change in treatment being imposed upon them
When planning your AHK-Cu dosage guide, treat it as a unique entity
This is important because peptide reconstitution is not controlled by the water alone